β3-Adrenergic receptor polymorphism and metabolic syndrome in postmenopausal women

Gynecological Endocrinology

Volumn 24, Issue 3, 2008, Pages 133-138

  Dunajska, Katarzyna ^a   Lwow, Felicja ^a   Milewicz, Andrzej ^a   Jȩdrzejuk, Diana ^b   Łaczmański, Łukasz ^b   Belowska Bień, Kinga ^b   Urban, Joanna ^b   Szuba, Andrzej ^b  

^a UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

3 Adrenergic receptor; Metabolic syndrome; Postmenopausal women

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AMINO ACID SUBSTITUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; METABOLIC SYNDROME X; POLAND; POLYMERASE CHAIN REACTION; POPULATION GENETICS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZATION; RECEPTOR GENE; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ARGININE; BLOOD GLUCOSE; CHOLESTEROL, HDL; FEMALE; GENOTYPE; HUMANS; INSULIN; LIPID A; METABOLIC SYNDROME X; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, ADRENERGIC, BETA-3; TRYPTOPHAN;

EID: 40549128304     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590801921686     Document Type: Article

References (44)

1. Zimmet P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 2005;50:31-33.
2. Bjorntrop P. Abdominal obesity and the development of non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1988;4:615-622.
3. Kissebah AH, Peiris AN. Biology of regional body fat distribution: relationship to non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1989;5:83-109.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1567.
5. Hubert HB, Fenileb M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983;67:968-977.
6. Welin L, Eriksson H, Larsson B, Svardsudd K, Wilhelmsen L, Tibblin G. Risk factors for coronary heart disease during 25 years of follow-up. The study of men born in 1913. Cardiology 1993;82:223-228.
7. Larsson B, Bengtsson C, Bjorntorp P, Lapidus L, Sjostrom L, Svardsudd K, Tibblin G, Wedel H, Welin L, Wilhelmsen L. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol.1992;135:266-273.
8. Gambacciani M, Ciaponi M, Cappagli B. Climacteric modifications in body weight and fat distribution. Climacteric 1999;2:37-44.
9. Pasquali R, Casimirri F, Labate A, Tortelli O, Pascal G, Anconetani B, Gatto MR, Flamia R, Capelli M, Barbara L. Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. Int J Obes Relat Metab Disord 1994;18:614-621.
10. Matthews KA, Abrams B, Crawford S, Miles T, Neer R, Powell LH, Wesley D. Body mass index in mid-life women: relative influence of menopause, hormone use and ethnicity. Int J Obes Relat Metab Disord 2001;25:863-873.
11. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87:4166-4170.
12. Poehlman ET. Menopause, energy expenditure and body composition. Acta Obstet Gynecol Scand 2002;81:603-611.
13. Milewicz A, Jedrzejuk D. Climacteric obesity: from genesis to clinic. Gynecol Endocrinol 2006;22:18-24.
14. 3- adrenoceptor gene variant in postmenopausal women. Diabetes 1999;48:1425-1428.
15. 3 adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-354.
16. 3 adrenergic receptor gene. N Engl J Med 1995;333:343-347.
17. 3 adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-351.
18. 3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin Chim Acta 1998;274:167-176.
19. 3 adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998;83:2441-2444.
20. 3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 1998;101:584-587.
21. 3 adrenergic receptor. Diabetes 1999;48:1863-1867.
22. 3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 1996;98:2086-2093.
23. 3 adrenergic receptor. Arch Med Res 1999;30:459-464.
24. 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab 1998;83:2892-2897.
25. 3- adrenergic receptor gene and the -3826 A → G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 young Danish subjects. J Clin Endocrinol Metab 2000;85:3151-3154.
26. 3-adrenergic receptor aminoacid variant is not associated with overweight and type 2 diabetes mellitus in Polish population. Exp Clin Endocrinol Diabetes 2005;113:593-597.
27. Katz A, Nambi SS, Mather K, Baron A, Follmann DA, Sullivan G, Quron MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410.
28. Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kita Y, Kadowaki T, Tsujita Y, Horie M, Miki T, Ueshima H. Relationship between metabolic syndrome and Trp64Arg polymorphism of the β-adrenergic receptor gene in a general sample: the Shigaraki study. Hypertens Res 2006;29:891-896.
29. 3-adrenergic receptor polymorphisms with midlife weight gain. Obes Res 2004;12:1212-1216.
30. 3 Adrenergic receptor polymorphism and obesity related phenotypes in hypertensive patients. Obes Res 2004;12:125-130.
31. 3-adrenergic receptor gene. Int J Obes Relat Metab Disord 2003;27:1028-1036.
32. 3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women. Maturitas 2003;45:39-45.
33. 3 adrenergic receptor genes. Med Sci Monit 2007;13:BR112-BR118.
34. 3 adrenergic receptor with insulin resistance. Obes Res 2005;13:1709-1719.
35. 3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese school-children with obesity. Int J Obes Relat Metab Disord 2000;24:443-449.
36. 3-adrenergic receptor gene and C161T substitution of the peroxisome proliferator activated receptor g gene polymorphism of the leptin receptor gene in Japanese children. Paediatr Int 2003;45:135-141.
37. 3-adrenergic receptor genes explained 18.3% of adolescent obesity variation. J Hum Genet 2005;50:365-369.
38. 2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients. Clin Chem Lab Med 2007;45:493-498.
39. 3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. J Intern Med 2001;250:348-360.
40. Ukkola O, Bouchard C. Clustering of metabolic abnormalities in obese individuals: the role of genetic factors. Ann Med 2001;33:79-90.
41. Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS. Interactive effects between polymorphisms in the β-adrenergic receptors and longitudinal changes in obesity. Obes Res 2005;13:519-526.
42. 3-adrenergic receptor gene in healthy Japanese men. J Epidemiol 2005;15:203-210.
43. 3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes Res 2001;9:741-745.
44. 3- adrenergic receptor gene is associated with reduced low-density lipoprotein particle size. Metabolism 2003;52:356-361.